A patient sat across from me not long ago and said, “I feel like I’m doing everything right, and still failing.” She had lost weight. She was taking her medications exactly as prescribed. She had reworked her diet along the lines we’d discussed. Yet her glucose readings remained stubbornly elevated.
I’ve heard some version of that sentence throughout my career as a physician and clinical researcher studying metabolism and diabetes. This time, it pushed me toward a question I don’t think we ask often enough in clinical practice: What if we are missing a variable in how we think about glycemic control?
That variable may be light.
Not light in a metaphorical sense. Light as a biological signal. The body’s circadian clocks use light to tell time, and those clocks do far more than regulate sleep. They influence hormone secretion, insulin sensitivity, mitochondrial function, and energy metabolism across a 24-hour cycle. For most of human history, the signal was simple and consistent: bright days, dark nights. Today, many of us spend our working hours indoors under dim, static lighting and our evenings under the bright, blue-enriched light of screens and household bulbs, in effect, darker days and brighter nights than the environment our physiology evolved to expect.
This is not a trivial mismatch. Shift workers, who experience the most extreme form of circadian misalignment, have consistently higher rates of obesity and type 2 diabetes. Controlled laboratory studies have shown why: experimentally induced circadian disruption impairs insulin sensitivity within days, independent of diet or activity.
Real physician voices, twice a week
Free, and one click to unsubscribe.
A more recent and, to me, more clinically striking line of evidence involves something as simple as where patients spend their daylight hours. In a randomized crossover trial, patients with type 2 diabetes spent significantly more time in a healthy glucose range when their office hours included exposure to natural daylight than when they worked under artificial indoor lighting alone. Nothing else about their meals or activity changed.
This lines up with something I’ve seen in my own research on meal timing. In a randomized trial my colleagues and I conducted, patients with type 2 diabetes who concentrated their calories into two larger meals earlier in the day, rather than six smaller meals spread evenly, lost more weight and improved insulin sensitivity more, despite identical caloric intake. Part of the explanation is that insulin sensitivity is higher earlier in the day. But what sets that daily rhythm in the first place is light. Meal timing and light exposure are not separate interventions; they are two ways of asking the same underlying question, which is whether we are working with the body’s circadian biology or against it.
There is even preliminary evidence that light may act on glucose metabolism more directly, and not only by setting the clock. In one small study, brief exposure to red light before a glucose challenge measurably blunted the post-meal blood sugar spike, with a proposed mechanism involving improved mitochondrial handling of glucose. This work is early, and it should be treated as hypothesis-generating rather than practice-changing. But it is consistent with a broader pattern: Light appears to touch metabolic physiology at more than one level.
None of this argues against diet, exercise, or pharmacotherapy, including the glucagon-like peptide-1 (GLP-1) receptor agonists that have transformed our ability to manage glycemic control and weight. It argues for adding a low-cost, low-risk variable to the conversation we are already having with patients, one that requires no prescription, no device, and no prior authorization.
In practice, that conversation can be brief:
- Encourage morning light exposure, ideally outdoors, ideally within the first hour or two of waking, as a way to anchor circadian rhythm.
- Ask about workspace lighting. Patients who can move a desk near a window, or take a short outdoor break during the workday, may be getting a meaningful metabolic benefit alongside the obvious ones.
- Advise dimming household lighting and screens in the evening, particularly in the hours before bed, when artificial brightness works against the body’s expected signal for darkness.
- Where relevant, frame meal timing and light exposure as complementary, not competing, interventions, both aimed at realigning metabolism with circadian biology.
None of these recommendations require new infrastructure or significant time in an already-compressed visit. What they require is a shift in how we think about the inputs that shape glycemic control. We have become very good at asking patients what they eat and how much they move. We rarely ask how much natural light they see, or when.
Diabetes guidelines will not be rewritten on the basis of a single trial, and they shouldn’t be. But the evidence for circadian and light-based influences on glucose metabolism has moved well past the point of being a curiosity. It belongs in the differential we run through when a patient like mine is doing everything we’ve asked and still not seeing the results either of us expects.
Sometimes the missing prescription isn’t a new drug. It’s a return to a signal our biology has been reading for far longer than we’ve been writing prescriptions at all.
Hana Kahleova is an endocrinologist.
